PortfoliosLab logoPortfoliosLab logo
ISIN
US7711951043

Highlights

EPS (TTM)
$5.42
PE Ratio
9.05
Total Revenue (TTM)
$107.65B
Gross Profit (TTM)
$79.28B
EBITDA (TTM)
$31.01B
Year Range
$37.51 - $60.85
Target Price
$57.00
ROA (TTM)
17.27%
ROE (TTM)
51.44%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

RHHBY Performance Chart

Roche Holding AG (RHHBY) is down 1.9% since the beginning of the year. At $49 per share, RHHBY is trading 19.4% below its 52-week high of $61. Investors who bought $1,000 worth of RHHBY shares 5 years ago would now be looking at an investment worth $1,327.


Loading charts...

S&P 500 Index

Returns By Period

Roche Holding AG (RHHBY) has returned -1.92% so far this year and 24.33% over the past 12 months. Over the last ten years, RHHBY has returned 7.15% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.


Roche Holding AG

1D
-2.29%
1M
-3.78%
YTD
-1.92%
6M
3.86%
1Y
24.33%
3Y*
10.46%
5Y*
5.82%
10Y*
7.15%

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RHHBY Monthly Returns History

Based on dividend-adjusted daily data since Jan 2, 2001, RHHBY's average daily return is +0.04%, while the average monthly return is +0.84%. At this rate, an investment would double in approximately 6.9 years.

Historically, 56% of months were positive and 44% were negative. The best month was Mar 2009 with a return of +25.4%, while the worst month was Feb 2009 at -20.1%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.

On a daily basis, RHHBY closed higher 46% of trading days. The best single day was May 8, 2001 with a return of +13.6%, while the worst single day was Mar 17, 2003 at -13.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202610.04%4.93%-13.96%2.35%2.99%-6.35%-1.92%
202512.53%6.34%1.93%-0.92%-1.15%1.14%-4.54%4.78%2.55%-3.37%18.39%7.82%52.86%
2024-3.01%-6.86%1.53%-6.58%7.34%8.31%16.84%4.49%-5.62%-2.85%-6.62%-3.75%0.23%
20230.00%-7.92%3.17%9.37%0.94%-3.51%1.31%-5.35%-7.37%-4.72%4.21%7.54%-4.02%
2022-6.00%-2.80%7.44%-6.54%-7.88%-1.95%-0.58%-2.48%0.45%1.77%-1.02%-4.33%-22.21%
2021-0.98%-5.32%0.61%0.37%7.49%7.38%2.70%4.06%-9.46%6.29%0.93%5.97%20.20%

Benchmark Metrics

Roche Holding AG has an annualized alpha of 6.89%, beta of 0.48, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since January 03, 2001.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (60.24%) than losses (50.04%) - typical of diversified or defensive assets.
  • Beta of 0.48 may look defensive, but with R2 of 0.15 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
6.89%
Beta
0.48
0.15
Upside Capture
60.24%
Downside Capture
50.04%

Return for Risk

Risk / Return Rank

RHHBY ranks 65 for risk / return — better than 65% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


RHHBY Risk / Return Rank: 6565
Overall Rank
RHHBY Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
RHHBY Sortino Ratio Rank: 6565
Sortino Ratio Rank
RHHBY Omega Ratio Rank: 6262
Omega Ratio Rank
RHHBY Calmar Ratio Rank: 6565
Calmar Ratio Rank
RHHBY Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Roche Holding AG (RHHBY) and compare them to S&P 500 Index.


RHHBYBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.91

2.39

-1.48

Sortino ratio

Return per unit of downside risk

1.50

3.25

-1.75

Omega ratio

Gain probability vs. loss probability

1.18

1.43

-0.25

Calmar ratio

Return relative to maximum drawdown

1.26

3.11

-1.85

Martin ratio

Return relative to average drawdown

3.16

14.38

-11.22

Dividends

Dividend History

Roche Holding AG provided a 3.16% dividend yield over the last twelve months, with an annual payout of $1.55 per share. The company has been increasing its dividends for 6 consecutive years.


1.50%2.00%2.50%3.00%3.50%4.00%$0.00$0.20$0.40$0.60$0.80$1.00$1.20$1.4020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$1.55$1.39$1.35$1.29$1.27$0.81$0.73$0.69$1.11$1.03$1.02$1.00

Dividend yield

3.16%2.69%3.87%3.55%3.23%1.57%1.66%1.70%3.58%3.25%3.57%2.91%

Monthly Dividends

The table displays the monthly dividend distributions for Roche Holding AG. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$1.55$0.00$0.00$0.00$1.55
2025$0.00$0.00$1.39$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.39
2024$0.00$0.00$1.35$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.35
2023$0.00$0.00$1.29$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.29
2022$0.00$0.00$1.27$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.27
2021$0.00$0.00$0.81$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.81

Dividend Yield & Payout


Dividend Yield

Roche Holding AG has a dividend yield of 3.16%, which is quite average when compared to the overall market.

Payout Ratio

Roche Holding AG has a payout ratio of 73.07%, which is quite average when compared to the overall market. This suggests that Roche Holding AG strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Roche Holding AG. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Roche Holding AG was 45.73%, occurring on Mar 2, 2009. Recovery took 567 trading sessions.

The current Roche Holding AG drawdown is 16.51%.


Related event

Drawdown

Fall

Recovery

Underwater

Financial crisis2007–2009
-45.73%Mar 2009
1y 2d2y 3mo
3y 3moFeb 2008 - May 2011
2024 bear market2024
-40.88%May 2024
2y 22d1y 6mo
3y 7moApr 2022 - Nov 2025
2003 bear market2003
-40.69%Mar 2003
2y 2mo9mo 6d
2y 11moJan 2001 - Dec 2003
2016 bear market2016
-27.32%Dec 2016
1y 6mo2y 2mo
3y 9moJun 2015 - Feb 2019
COVID crash2020
-20.28%Mar 2020
21d1mo 11d
2mo 2dFeb 2020 - Apr 2020

Drawdown Indicators


RHHBYBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-45.73%

-56.78%

+11.05%

Max Drawdown (1Y)

Largest decline over 1 year

-19.38%

-9.10%

-10.28%

Max Drawdown (3Y)

Largest decline over 3 years

-24.58%

-18.90%

-5.68%

Max Drawdown (5Y)

Largest decline over 5 years

-40.88%

-25.43%

-15.45%

Max Drawdown (10Y)

Largest decline over 10 years

-40.88%

-33.92%

-6.96%

Current Drawdown

Current decline from peak

-16.51%

0.00%

-16.51%

Average Drawdown

Average peak-to-trough decline

-12.84%

-10.72%

-2.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.71%

1.97%

+5.74%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Roche Holding AG over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Roche Holding AG is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for RHHBY, comparing it with other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/E ratio of 9.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for RHHBY relative to other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with RHHBY

Add Roche Holding AG to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with RHHBY